scholarly article | Q13442814 |
P50 | author | Keri Csencsits-Smith | Q59917199 |
P2093 | author name string | Guanyi Lu | |
D Keith Bishop | |||
Svetlana Grabauskiene | |||
Bryna E Burrell | |||
P2860 | cites work | NFATc2 and T-bet contribute to T-helper-cell-subset-specific regulation of IL-21 expression | Q24556668 |
Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin | Q28589387 | ||
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 | ||
The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells | Q29614226 | ||
IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells | Q29616148 | ||
Phenotypic and functional features of human Th17 cells | Q29619323 | ||
IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 | ||
Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. | Q33740453 | ||
The role of CD154 in organ transplant rejection and acceptance | Q33772261 | ||
The role of TNF receptor and TNF superfamily molecules in organ transplantation | Q34719084 | ||
Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction? | Q35072090 | ||
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction | Q35072094 | ||
Heterologous immunity provides a potent barrier to transplantation tolerance | Q35095576 | ||
CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses | Q35231921 | ||
Effector mechanisms in transplant rejection | Q35583498 | ||
Heterologous immunity: an overlooked barrier to tolerance | Q35583521 | ||
CD40/CD154 interactions at the interface of tolerance and immunity | Q35698455 | ||
Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease | Q36228235 | ||
T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17 | Q36228767 | ||
Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation | Q36229698 | ||
The T-box transcription factor T-bet in immunity and autoimmunity | Q36476813 | ||
The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease | Q36747499 | ||
Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment | Q40130406 | ||
Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6. | Q40132546 | ||
Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells | Q40757721 | ||
Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? | Q41389910 | ||
T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. | Q42742129 | ||
Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. | Q46001789 | ||
Origins of the T(H)1-T(H)2 model: a personal perspective | Q46303124 | ||
Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. | Q46541813 | ||
Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. | Q51065721 | ||
High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. | Q52039522 | ||
T-cell costimulatory pathways in allograft rejection and tolerance | Q56902638 | ||
The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts | Q56904634 | ||
IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways | Q56907841 | ||
What does it mean to be just 17? | Q59072217 | ||
Inhibition of Th1 Development Mediated by GATA-3 through an IL-4-Independent Mechanism | Q61357092 | ||
Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection | Q68054864 | ||
IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity | Q71396687 | ||
In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection | Q72196808 | ||
Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions | Q73509932 | ||
The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells | Q74464420 | ||
Alloantigen-reactive Th1 development in IL-12-deficient mice | Q74506164 | ||
Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet | Q77476285 | ||
Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis | Q79236402 | ||
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis | Q79755041 | ||
Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection | Q79929535 | ||
Understanding the IL-23-IL-17 immune pathway | Q81485100 | ||
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis | Q82136598 | ||
Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection | Q93747372 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3906-3914 | |
P577 | publication date | 2008-09-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice | |
P478 | volume | 181 |
Q39835072 | A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity |
Q90701402 | A novel model for dissecting roles of IL-17 in lung transplantation |
Q48025939 | A pathogenic role of IL- 17 at the early stage of corneal allograft rejection |
Q54628324 | Absence of IL-23p19 in donor allogeneic cells reduces mortality from acute GVHD. |
Q36280335 | Absence of MyD88 signaling induces donor-specific kidney allograft tolerance |
Q44561822 | Absence of donor CD40 protects renal allograft epithelium and preserves renal function. |
Q54418980 | Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival. |
Q38081174 | CD4(+) T-cell subsets in transplantation |
Q35816448 | CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients |
Q33913346 | CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors |
Q34484754 | Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. |
Q33811918 | Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. |
Q37373747 | Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection |
Q50002899 | Differential modulation of IL-12 family cytokines in autoimmune islet graft failure in mice |
Q37977126 | Direct and indirect regulatory mechanisms in TH17 cell differentiation and functions |
Q85203273 | Eicosapentaenoic Acid Disrupts the Balance Between Tregs and IL-17+ T Cells Through PPARγ Nuclear Receptor Activation and Protects Cardiac Allografts |
Q85370236 | Expression levels of Notch1 and Delta-like 4 in peripheral lymphocytes and their relationship with T helper 17 (Th17) cells in renal transplant recipients |
Q38216200 | Heterogeneity in the differentiation and function of CD8⁺ T cells |
Q35022593 | IL-17A and IL-2-expanded regulatory T cells cooperate to inhibit Th1-mediated rejection of MHC II disparate skin grafts |
Q35032693 | IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts |
Q38328539 | IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity. |
Q35566506 | IL-6 promotes cardiac graft rejection mediated by CD4+ cells |
Q37864694 | Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells |
Q38008077 | Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation |
Q39440909 | Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms. |
Q33823699 | Inflammation and transplantation tolerance |
Q42025217 | Innate immunity and resistance to tolerogenesis in allotransplantation |
Q34086917 | Interleukin-17 promotes early allograft inflammation |
Q37273910 | Interleukins 17 and 23 influence the host response to Histoplasma capsulatum |
Q57462291 | Loss of T-bet confers survival advantage to influenza-bacterial superinfection |
Q37836540 | Loss of tolerance to self after transplant |
Q43106558 | Mycophenolic acid suppresses granulopoiesis by inhibition of interleukin-17 production |
Q36694466 | NK cells inhibit T-bet-deficient, autoreactive Th17 cells |
Q88200625 | Platelet factor 4 protects kidney allograft in a rat kidney transplantation model |
Q35813877 | Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis. |
Q56547729 | RETRACTED: Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation |
Q37721479 | Recent progress and new perspectives in studying T cell responses to allografts |
Q42232279 | Regulatory role of CD4(+)CD25 (+)Foxp3 (+) regulatory T cells on IL-17-secreting T cells in chronic hepatitis B patients |
Q37622866 | Role of Th17 cells and IL-17 in lung transplant rejection |
Q37411201 | Sequential evolution of IL-17 responses in the early period of allograft rejection. |
Q28486264 | Significance and suppression of redundant IL17 responses in acute allograft rejection by bioinformatics based drug repositioning of fenofibrate |
Q37012868 | Structure and function of major histocompatibility complex class I antigens |
Q46019531 | T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. |
Q38185124 | T helper subsets & regulatory T cells: rethinking the paradigm in the clinical context of solid organ transplantation |
Q37891668 | T-bet in disease. |
Q42110315 | T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation |
Q28589692 | T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt |
Q33873078 | T-cell co-stimulatory blockade in kidney transplantation: back to the bench |
Q38148197 | T-cell co-stimulatory blockade in transplantation: two steps forward one step back! |
Q36749425 | TIM-3: a novel regulatory molecule of alloimmune activation. |
Q33711191 | TLR signals promote IL-6/IL-17-dependent transplant rejection. |
Q37249890 | Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. |
Q38150101 | Targeting co-stimulatory pathways: transplantation and autoimmunity |
Q54976588 | Targeting the class IA PI3K isoforms p110α/δ attenuates heart allograft rejection in mice by suppressing the CD4+ T lymphocyte response. |
Q34856750 | Tc17 CD8 T cells: functional plasticity and subset diversity. |
Q38254602 | Tc17 Cells in Immunity and Systemic Autoimmunity |
Q35327827 | Th17 cells and transplant acceptance |
Q53385340 | Th17 cells induce a distinct graft rejection response that does not require IL-17A. |
Q37771228 | The impact of Th17 cells on transplant rejection and the induction of tolerance |
Q37587334 | Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production |
Q35164666 | Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation. |
Q51007543 | γδ T cell receptor deficiency attenuated cardiac allograft vasculopathy and promoted regulatory T cell expansion. |
Search more.